You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Curcumin as a Potential Treatment for COVID-19
|
|---|---|
| Published in |
Frontiers in Pharmacology, May 2021
|
| DOI | 10.3389/fphar.2021.675287 |
| Pubmed ID | |
| Authors |
Bruna A. C. Rattis, Simone G. Ramos, Mara R. N. Celes |
X Demographics
The data shown below were collected from the profiles of 270 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Turkey | 22 | 8% |
| United States | 15 | 6% |
| United Kingdom | 4 | 1% |
| Canada | 3 | 1% |
| Mongolia | 2 | <1% |
| India | 2 | <1% |
| France | 2 | <1% |
| Bolivia, Plurinational State of | 1 | <1% |
| Japan | 1 | <1% |
| Other | 7 | 3% |
| Unknown | 211 | 78% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 259 | 96% |
| Practitioners (doctors, other healthcare professionals) | 7 | 3% |
| Scientists | 4 | 1% |
Mendeley readers
The data shown below were compiled from readership statistics for 223 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 223 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 9% |
| Student > Master | 19 | 9% |
| Student > Bachelor | 19 | 9% |
| Student > Ph. D. Student | 14 | 6% |
| Other | 12 | 5% |
| Other | 32 | 14% |
| Unknown | 107 | 48% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 19 | 9% |
| Biochemistry, Genetics and Molecular Biology | 18 | 8% |
| Agricultural and Biological Sciences | 16 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 7% |
| Chemistry | 14 | 6% |
| Other | 32 | 14% |
| Unknown | 108 | 48% |
Attention Score in Context
This research output has an Altmetric Attention Score of 212. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2024.
All research outputs
#192,149
of 26,212,054 outputs
Outputs from Frontiers in Pharmacology
#85
of 20,170 outputs
Outputs of similar age
#5,608
of 458,684 outputs
Outputs of similar age from Frontiers in Pharmacology
#7
of 921 outputs
Altmetric has tracked 26,212,054 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 20,170 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 458,684 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 921 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.